+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Gene Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Therapeutic Injectable Drugs - Devices, Products and Markets - Product Thumbnail Image

Therapeutic Injectable Drugs - Devices, Products and Markets

  • Report
  • June 2023
  • 235 Pages
  • Global
From
From
From
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 240 Pages
  • Global
From
From
From
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
From
B-cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 450 Pages
  • Global
From
From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • November 2024
  • 293 Pages
  • Global
From
Loading Indicator